The Bottom Line on Hernia Mesh Manufacturers
Hernia mesh is used in at least 90% of hernia repair surgeries and has become the chief form of treatment doctors recommend when surgery is required to treat a hernia. There are several hernia mesh devices on the market, but many models have been recalled by the FDA and/or their manufacturers after the discovery that the devices posed serious health risks to patients.
Hernia Mesh Is Big Business
Hernia mesh devices brought their manufacturers a whopping $3.6 billion in 2020 alone, a figure that is forecast to grow to $5.8 billion by 2025. The jump in revenue is expected to derive from several emerging trends.
First, due to recommendations adopted internationally in 2018, there has been a marked increase in demand for hernia mesh products. Second, hernia recurrence — often a result of hernia mesh failure itself — is a growing problem in the medical field that is driving demand for mesh devices. Finally, advances in robotic surgery techniques will make hernia mesh placement feasible in a greater number of procedures in the coming years, which is expected to add dramatically to demand.
Hernia Mesh Manufacturers Sponsor Studies Recommending Hernia Mesh
There is quite an incentive for hernia mesh manufacturers to continue to produce, promote, and sell hernia mesh devices despite the known harms and the possibility of patient lawsuits; on balance, the devices bring their producers more money than they cost them. It is no surprise, then, that hernia mesh makers seek to sponsor research that deems their products safe and effective and that they offer grants to research projects that they expect will produce such results.
In fact, the aforementioned hernia surgery standards announced in 2018 were the result of a study published by HerniaSurge Group and funded chiefly by Bard Pharmaceuticals and Johnson & Johnson. Those guidelines recommend hernia mesh as the first-line treatment in hernia surgery procedures and even recommend that no other options but mesh devices be considered or mentioned unless the patient makes a specific request or there is not an appropriate hernia mesh device available.
The Bottom Line
The public often expects that any outfit that repeatedly produces products that harm consumers will be eliminated from the market. While that may sometimes be the case, it is not always a straightforward matter, especially in industries as lucrative as pharmaceuticals and medical devices.
For example, though Bard was forced to settle with around 2000 individuals for $184 million in Multidistrict Litigation (MDL) in 2011, as one of the major players in a multi-billion dollar industry, the firm’s leadership — following advice from accountants and attorneys — considers lawsuits a cost of doing business rather than a reason to stop producing a device.
The financial bottom line — not the health and safety of patients — comes first and foremost for pharmaceutical and medical device firms and is the chief factor preventing the release of dangerous devices, which the steady march of recalls and lawsuits demonstrate is an ineffective guardrail for patient safety. Until the industry’s business practices change, patients must rely on consumer advocate attorney’s hernia Mesh Lawsuits to recoup their medical expenses and compensation for missed work, trauma, and pain in the event of a complication.